Abstract

Deferiprone (1, 2 dimethyl-3-hydroxypyrid-4-one) is considered to be the standard iron chelator. Pharmacokinetic studies of generic formulations are required in local condition before placed on the market. High performance liquid chromatographic (HPLC) method was used for quantification of deferiprone in human plasma using UV/VIS detector. Chromatographic separation was carried out on C(18) column, with a mobile phase of methanol-buffer (18:82, v/v), pH 3.5, and caffeine was used as an internal standard. The calibration curve was linear over the range 0.25-10 μg/mL in human plasma (R(2) = 0.9994). After oral administration of deferiprone (500 mg) to human, the plasma concentration-time curve of deferiprone was conformed to two-compartment open model. The deferiprone plasma concentration showed a rapid absorption and average area under the plasma concentration-time curve (AUC) of deferiprone was 17.0 ± 1.23 h.μg/ml. Average absorption and elimination half-life values of deferiprone of 24 volunteers were 0.62 ± 0.12 and 2.65 ± 0.43 hours. This study confirms the rapid absorption of deferiprone in humans. AUC was similar to that previously reported but C(max) was slightly lower than that stated in the literature.

Links

Aggregator Full Text

Authors

Abbas M, Nawaz R, Iqbal T, Alim M, Asi MR

Institution

Quality Operations Laboratory (QOL), University of Veterinary and Animal Sciences (UVAS), Lahore, Pakistan. hafizmateen2002@yahoo.com

Source

Pakistan journal of pharmaceutical sciences 25:2 2012 Apr pg 343-8

MeSH

Chelating Agents
Chromatography, High Pressure Liquid
Chromatography, Reverse-Phase
Humans
Male
Pyridones

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

22459459